Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann C Collier

Showing results (1-10 of 184) with videos related to

Pageof 19
Sort By:
Current HIV/AIDS Reports|August 11, 2005
Primary HIV InfectionJoanne Stekler, Ann C Collier
AIDS (London, England)|April 2, 2005
Lack of interaction between atazanavir and lansoprazoleBradley W Kosel, Sheryl S Storey, Ann C Collier
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2006
Primary HIV infection education: knowledge and attitudes of HIV-negative men who have sex with men attending a public health sexually transmitted disease clinicJoanne Stekler, Ann C Collier, King K Holmes, et al.
Plos One|June 12, 2013
Anthropometric differences between HIV-infected individuals prior to antiretroviral treatment and the general population from 1998-2007: the AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (ALLRT) cohort and NHANESBenjamin E Atkinson, Supriya Krishnan, Gary Cox, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 6, 2006
Pretreatment factors associated with 3-year (144-week) virologic and immunologic responses to potent antiretroviral therapyRonald J Bosch, Kara Bennett, Ann C Collier, et al.
BMC Infectious Diseases|May 4, 2007
Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapyChristina M Marra, Clare L Maxwell, Ann C Collier, et al.
BMC Infectious Diseases|March 1, 2006
A prospective study of hearing changes after beginning zidovudine or didanosine in HIV-1 treatment-naïve peopleJeffrey T Schouten, David W Lockhart, Thomas S Rees, et al.
The Journal of Infectious Diseases|September 20, 2005
A randomized study of serial telephone call support to increase adherence and thereby improve virologic outcome in persons initiating antiretroviral therapyAnn C Collier, Heather Ribaudo, A Lisa Mukherjee, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 13, 2010
Relationship between CD4+ T-cell counts/HIV-1 RNA plasma viral load and AIDS-defining events among persons followed in the ACTG longitudinal linked randomized trials studyMarlene Smurzynski, Kunling Wu, Constance A Benson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 17, 2011
Complex drug interactions of HIV protease inhibitors 1: inactivation, induction, and inhibition of cytochrome P450 3A by ritonavir or nelfinavirBrian J Kirby, Ann C Collier, Evan D Kharasch, et al.
Pageof 19

Showing results (1-10 of 184) with videos related to

Sort By:
Pageof 19
Current HIV/AIDS Reports|August 11, 2005
Primary HIV InfectionJoanne Stekler, Ann C Collier
AIDS (London, England)|April 2, 2005
Lack of interaction between atazanavir and lansoprazoleBradley W Kosel, Sheryl S Storey, Ann C Collier
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2006
Primary HIV infection education: knowledge and attitudes of HIV-negative men who have sex with men attending a public health sexually transmitted disease clinicJoanne Stekler, Ann C Collier, King K Holmes, et al.
Plos One|June 12, 2013
Anthropometric differences between HIV-infected individuals prior to antiretroviral treatment and the general population from 1998-2007: the AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (ALLRT) cohort and NHANESBenjamin E Atkinson, Supriya Krishnan, Gary Cox, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 6, 2006
Pretreatment factors associated with 3-year (144-week) virologic and immunologic responses to potent antiretroviral therapyRonald J Bosch, Kara Bennett, Ann C Collier, et al.
BMC Infectious Diseases|May 4, 2007
Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapyChristina M Marra, Clare L Maxwell, Ann C Collier, et al.
BMC Infectious Diseases|March 1, 2006
A prospective study of hearing changes after beginning zidovudine or didanosine in HIV-1 treatment-naïve peopleJeffrey T Schouten, David W Lockhart, Thomas S Rees, et al.
The Journal of Infectious Diseases|September 20, 2005
A randomized study of serial telephone call support to increase adherence and thereby improve virologic outcome in persons initiating antiretroviral therapyAnn C Collier, Heather Ribaudo, A Lisa Mukherjee, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 13, 2010
Relationship between CD4+ T-cell counts/HIV-1 RNA plasma viral load and AIDS-defining events among persons followed in the ACTG longitudinal linked randomized trials studyMarlene Smurzynski, Kunling Wu, Constance A Benson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 17, 2011
Complex drug interactions of HIV protease inhibitors 1: inactivation, induction, and inhibition of cytochrome P450 3A by ritonavir or nelfinavirBrian J Kirby, Ann C Collier, Evan D Kharasch, et al.
Pageof 19